<SEC-DOCUMENT>0001193125-17-202543.txt : 20170721
<SEC-HEADER>0001193125-17-202543.hdr.sgml : 20170721
<ACCEPTANCE-DATETIME>20170613165833
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-17-202543
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20170613

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
		CENTRAL INDEX KEY:			0001299130
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				161590339
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		1305 O'BRIEN DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		650-521-8000

	MAIL ADDRESS:	
		STREET 1:		1305 O'BRIEN DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PACIFIC BIOSCIENCES OF CALIFORNIA INC
		DATE OF NAME CHANGE:	20050829

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NANOFLUIDICS INC
		DATE OF NAME CHANGE:	20040729
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g412792g53x69.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;13, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><U>Via EDGAR and E-mail </U></I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities and
Exchange Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F
Street, N.E. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549-3720 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left">Attention:</TD>
<TD ALIGN="left" VALIGN="top">Martin James </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Eric Atallah </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Timothy Buchmiller </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Caleb French </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Pacific Biosciences of California, Inc. </B></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Form 10-K for the Fiscal Year Ended December&nbsp;31, 2016 </B></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Filed March&nbsp;6, 2017 </B></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD ALIGN="left" VALIGN="top"><B>File No.&nbsp;001-34899 </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pacific Biosciences of California, Inc. (the &#147;<B>Company</B>&#148;) is submitting this letter in response to comments from the staff (the
&#147;<B>Staff</B>&#148;) of the Securities and Exchange Commission set forth in a letter dated May&nbsp;31, 2017 (the &#147;<B>Comment Letter</B>&#148;) with respect to the above-referenced Annual Report on Form 10-K for the Fiscal Year Ended
December&nbsp;31, 2016 (the &#147;<B>2016 Annual Report</B>&#148;) filed on March&nbsp;6, 2017 (File No.&nbsp;001-34899). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For your
convenience, the Staff&#146;s comments set forth in the Comment Letter have been reproduced in bold and italics herein with responses immediately following each comment. References to &#147;we,&#148; &#147;our&#148; or &#147;us&#148; mean the
Company or its advisors, as the context may require. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Note 9. Stockholders&#146; Equity, page 66 </U></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 13, 2017 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Stock-based Compensation, page 68 </U></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>1.</I></B></TD>
<TD ALIGN="left" VALIGN="top"><B><I>We note that in determining the fair value of your employee stock options and your ESPP you have used an expected volatility of 70.0% for years ended December&nbsp;31, 2016, 2015, and 2014, respectively. We also
note from your disclosure on page 56 that your expected volatility is based on the historical volatility of your common stock as well as several comparable publicly listed companies. Please address the following: </I></B></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B><I>&#149;</I></B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Explain to us how you weight your historical volatility and the volatility of comparable publicly listed companies in determining your overall expected volatility. Also explain why your expected volatility has
remained unchanged for the last 3 years. </I></B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company advises the Staff that it develops estimates of the expected
volatility of its common stock on a quarterly basis. In doing so, the Company uses the guidance in ASC 718-10-55-35 through 55-41, as well as SAB Topic 14.D.1. The objective of the Company&#146;s estimates is to develop assumptions marketplace
participants would likely use to determine an exchange price of the Company&#146;s options. In doing so, the Company calculates and considers factors such as the historical volatility of the Company&#146;s common stock (in accordance with ASC
718-10-55-37.a) as well as the length of time the Company&#146;s common stock has been traded and the expected volatility of similar entities (in accordance with ASC 718-10-55-37.c). The Company advises the Staff that it does not have data to derive
implied volatility (in accordance with ASC 718-10-55-37.b). The Company takes this approach because, consistent with ASC 718-10-55-38, using the unadjusted historical volatility of the Company&#146;s common stock alone may not be appropriate as
marketplace participants would not use it without considering the extent to which the future may differ from the past. The Company also reviewed SAB Topic 14.D.1, which indicates that the Staff would not object to the exclusive use of historical
volatility if the methodology is applied consistently and certain factors are present. However, this is not the approach the Company has historically adopted and used. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because volatility is a forward-looking estimate used to project the extent of stock price fluctuations over multiple years, the Company
believes the weighting of different factors is highly judgmental and not mechanical. For illustration purposes, the Company has listed below the factors it considered and the basis for the Company&#146;s conclusions with respect to such factors as
of December&nbsp;31, 2016 (the Company&#146;s most recent annual balance sheet date) and December&nbsp;31, 2015 (the corresponding prior year&#146;s balance sheet date). The Company has performed and documented similar estimation processes in prior
periods, consistent with the requirements of ASC 718-10-55-40 and 55-41. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 13, 2017 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company observed that, even though its common stock has traded since October 2010 (i.e.,
for approximately 6.2 years by December&nbsp;31, 2016), the Company is still early in its life cycle and, accordingly, its historical volatility is likely not relevant to future periods. In particular, prior to early 2011, the Company primarily
focused on developing its technology and it launched the Company&#146;s first instrument product, the PacBio RS, in 2011. However, the Company&#146;s instrument revenue declined from $30.2 million in 2011 to $15.5 million in 2012 and further to
$11.5 million in 2013. In 2013, the Company introduced instrument enhancements to improve reliability and performance by launching the PacBio RS II. Still, while the Company&#146;s instrument revenue grew to $22.1 million in 2014, it declined again
to $18.7 million in 2015. The Company announced and started shipping its new platform, the Sequel System, which provides significant productivity enhancements over the Company&#146;s PacBio RS and RS II products, in the second half of 2015. The
Company was able to increase its instrument revenues to $41.0 million in 2016 and $12.6 million in the quarter ended March&nbsp;31, 2017. The Company also had a restructuring in 2011, and its number of employees has fluctuated from 431 in 2010 to
slightly over 300 in 2011-2014 before increasing back to 438 in 2016. The Company does not currently anticipate a repeat of the same pattern during future years commensurate with the expected term of its outstanding options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of the Company&#146;s history, as noted in the preceding paragraph, in addition to considering its historical stock volatility over
the prior 6-years (consistent with the estimated term of the Company&#146;s options) the Company also calculates and considers its volatility over the most recent 12-month period. This has generally provided an indication that the volatility rates
were trending down as compared to the volatility observed immediately after the Company&#146;s initial public offering and during its initial product introductions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company does not have implied volatility data, therefore it also obtains additional data points about its expected volatility by looking
at the volatility of other industry participants. The Company selects entities that it believes have operations similar to the Company. When there are no comparable peer companies present (e.g., because they were acquired or grew too large compared
to the Company), the Company looks at the most recent historical volatility of peer entities when they were believed to be comparable. In all instances, the Company measures their historical volatility based on the term commensurate with the
expected term of the Company&#146;s options. In selecting the peer entities, the Company applies the factors listed in SAB Topic 14.D.1 Question 6 (&#147;industry, stage of life cycle, size and financial leverage&#148;). The Company believes that
the resulting data is relevant for purposes of estimating its expected volatility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below the Company has presented certain data that was
used to determine its volatility for 2016 and 2015. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 13, 2017 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,&nbsp;2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,&nbsp;2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company historical data since IPO (2010)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company historical data for the most recent 12 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Highest of peer company volatilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average of peer companies&#146; volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average of Company and peer companies&#146; volatilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similar amounts resulted from the Company&#146;s estimation process at other reporting dates. As part of the
Company&#146;s analysis, it is additionally noted that had the historical volatility of the Company&#146;s common stock been solely relied on to develop the volatility assumptions for options granted in 2015 and 2016, the resulting impact would not
have been material. Based on the above, the Company concluded, originally during the year ended December&nbsp;31, 2014, that 70% is a reasonable estimate of its expected volatility. Based on the Company&#146;s quarterly estimation process, there
have been no significant changes in the data or the Company&#146;s business subsequent to such initial conclusion that the Company believes would warrant revisions to this amount. In supporting the Company&#146;s conclusion, it believes that the
expected volatility is closer to the Company&#146;s historical data than to the peer companies&#146; volatility. At the same time, the Company believes peer companies&#146; volatility provides an indication of future volatility, which is also
supported. by the recent downward trend in the Company&#146;s volatility, as illustrated for example, in its most recent 12 months&#146; volatility number (however, the Company does not believe it can solely rely on its most recent 12 months&#146;
historical volatility as it covers too short of a period when compared to the expected term of its options). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B><I>&#149;</I></B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>As the company has been a public company since 2010, please tell us when you expect to no longer consider the volatility rates of comparable publicly listed companies when estimating your expected volatility.
Refer to ASC 718-10-55-37 and Question 6 of SAB Topic 14.D.1. </I></B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As noted above, the Company plans to continue to
assess the relevant inputs for its volatility calculations on a quarterly basis, and how to weight different data. The Company does not anticipate significant changes to its process until at least December&nbsp;31, 2017. The Company believes its
current process is consistent with ASC 718-10-55-38, which requires entities to consider adjustments to the historical volatility amounts where appropriate to derive expected volatility. The Company does not believe its current approach is
inconsistent with SAB Topic 14.D.1 Question 6, as the Company does not believe it currently has sufficient Company-specific information available. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>2.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>As a related matter, we note from page 56 that the expected term of your options is estimated based on the
simplified method because you have limited historical </I></B></P></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 13, 2017 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 5
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>
information available. Please tell us how you have considered the extent of your exercise activity since your initial public offering in your determination to use the simplified method. Also tell
us when you expect that sufficient historical information will be available. Refer to Question 6 of SAB Topic 14.D.2. </I></B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company advises the Staff that its estimates of expected term are part of the same quarterly close process as the volatility estimates
described above in response to Comment No.&nbsp;1. ASC 718-10-55-31 provides various factors entities should assess when determining the expected term, including the awards&#146; vesting period, historical exercise and termination behavior for
similar grants, stock price volatility, blackout periods and employees&#146; ages, length of service and home jurisdictions. As the Company continues to accumulate its historical exercise and termination behavior, the Company reassesses from time to
time whether its historical data is sufficient and reasonable. The Company also notes that the simplified method is consistent with the assertion that employees exercise options at approximately an even pace in each period from the vesting date to
the expiration date. Thus, what amounts to the &#147;simplified method&#148; is anticipated will produce a reasonable estimate of the expected term as long as the exercise and termination behavior does not deviate significantly from such pattern.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company notes that its options provide for a maximum contractual term of 10 years. Thus, the Company&#146;s oldest options granted at
or after its IPO still have several years before they will begin to expire. Further, the Company&#146;s most recent options are relatively early in their lifecycle and many are not yet vested. Also, apart from the exercises and terminations
triggered by the Company&#146;s restructuring in 2011, the Company has not historically had significant exercises or cancellations of options. For example, the Company had 1.2&nbsp;million options exercised or cancelled during the year ended
December&nbsp;31, 2016, which was less than 5% of total options outstanding, and less than 10% of options exercisable. Further, only approximately 4.3&nbsp;million options outstanding and 3.7&nbsp;million options exercisable were &#147;in the
money&#148; at December&nbsp;31, 2016 (less than 20% of options outstanding and less than 30% of options exercisable). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As discussed above
in response to Comment No.&nbsp;1, the Company has experienced substantial volatility in its business, including fluctuations in its instrument sales and introductions of new products, as well as volatility of its stock price (for instance the
Company&#146;s stock price was $16.10 at its IPO, reached a high of $16.97 on October&nbsp;28, 2010, and went down to $1.10 on November&nbsp;13, 2012). The last reported sale price of the Company&#146;s common stock on June&nbsp;9, 2017 was $3.35,
and as noted above in response to Comment No.&nbsp;1, at December&nbsp;31, 2016, less than 20% of the Company&#146;s outstanding options and less than 30% of the Company&#146;s exercisable options have exercise prices below this stock price. Thus,
there are currently no significant economic incentives to exercise. Also, the Company believes that historical data </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 13, 2017 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 6
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
accumulated from exercises or terminations of options with high exercise prices is not relevant when the Company determines the expected term for the options with exercise prices based on current
stock fair values. Additionally, the Company hopes that a continuing focus on the execution of its business plan will result in future increases in its stock price, which would likely accelerate the pace of option exercises. The Company also notes
that options granted at this time will not be exercisable for 12-48 months from the grant date due to vesting provisions, further increasing the subjectivity of the Company&#146;s estimates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the above considerations, including those outlined in response to Comment No.&nbsp;1, the Company concluded that at December&nbsp;31,
2016 (and prior dates), it did not yet have sufficient historical information to rely on for purposes of determining the expected term of its options. Therefore, the Company believes the assertion of exercises at an even pace over the period from
vesting to maximum contractual term date (which equates to the &#147;simplified method&#148;) remains reasonable for current option grants. The Company does not anticipate significant changes to this assessment until at least December&nbsp;31, 2017.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the reasons noted above, the Company believes that this approach is consistent with SAB Topic 14.D.1 Question 6. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Note 11 &#150; Segment and Geographic Information, page 70 </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>3.</I></B></TD>
<TD ALIGN="left" VALIGN="top"><B><I>We note that you include all revenues attributed to customers in North America in one line item. In future filings, please separately disclose revenues for the United States, your country of domicile, in
accordance with ASC 280-10-50-41(a). </I></B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company acknowledges the Staff&#146;s comment, and, in future filings, the
Company will include appropriate separate disclosure regarding revenues for the United States in accordance with ASC 280-10-50-41(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* *
* * * </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you have any questions or comments regarding this letter, please do not hesitate to contact me at (650)&nbsp;521-8000. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Susan K. Barnes</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Susan K. Barnes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chief Financial Officer</TD></TR>
</TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 13, 2017 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 7
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top">Michael Hunkapiller, Chief Executive Officer, Pacific Biosciences of California, Inc. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Donna Petkanics, Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Andrew Hoffman, Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Richard Ramko, Ernst&nbsp;&amp; Young LLP </TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g412792g53x69.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g412792g53x69.jpg
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M 1$  A$! Q$!_\0 'P   @(" @,!              D("@8'!0L! P0"_\0
M3!   00" 0,"! (#"! $!P  ! (#!08!!P@ "1$2$PH4%2$6(B,Q.1<9)#)8
M=Y>W&!HS-S@Z05ES=7B6L[;6US1TD[@E45=VI;75_\0 '@$!  (" P$! 0
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M/TB-B68JAE+AFTC+?XB1P9''B51/@9D>=&LC=C<&'-D>XZ,8QQ<]Q#6@D@*
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MX$<EJIMJ'>D#Z!*O"U?<E+&=SEBW:].+;^H^T*M:&%6.N*S^(*H6I3*V98/
M#Q"8F5EARLU/,8) _P#*='CK:>/B.([>PE?*MN&R7"]L.1,1RY4LAAQFF;)B
M&6,4D;9^&XU%&[H-Z0-<\4-</^3Q&,!P=3R=,UAJ:>F?'V752M5=O56K=VJ$
ML'/U2X0,1:*S.1[GN@3,!/1X\I#R@;GC&5BGQY0Y3"LI3G+3J<Y3C/G&/T (
M< 0;@BX/6"O"3$</K<(Q"NPK$J:2CQ'#*RIH*^DF&[-2UE',^GJ:>5MR!)#-
M&^-X!(WFFQ(60=2M-'1%J_=_]Y;;W\U]_P#^5);J1Q'>/-0>![CY*OQVWNX+
MKWCIQBAM:6/37(Z[28=NM\LN=UIKF)LM6=9ECVWV1F)0RW0SRS!DIR@QG(24
MLN9PE+CGZ^LCFDFXMP5&NT L3W!3N?[O.KE-+3&<8>9AYZL>D0->H8,=!#^?
MLVTIYJ]&.MI4KQC*FQ2%X_6EE>?RYKN'K"MO?X7>Y:9US2M\\M>4U8YM\G-=
MG<=./_&^!E)O6E#N:B!K.8_%L&RZK+-AG"1\D&R$1ANSS$R;%Q0SS4)7X2&"
MDQVI.91.@%@;D]7W\.TG11J3<BP'7]\O/NTS[MC14KO;9G)GGY< GV3-QW(S
M7VJ&#D_PB'UA5'PT+985^9M;+F(ZKUYYUG+>%2E.EW,MX^;5G,.T :.7'[]_
MO4MUN[K.GAI?AWKB.[%6IO4=IXV<\:&$X[8]$7R+K%W0-^C<EJ+.'/% !GD8
MQCV8MPMZP5,C.%86O]T!*$^/3ZDF:W:>!^_ON4/N+$<EP/>@O@%RX3Z6L%2E
M,$4O9^X->3#$NSG/L'UN5UW>;'#K<QC.<>V__ I'V\YSE+@2,?K3GHSVCW'S
M".L0.TC7Y_\ U.TAHH""AXJ$BF&QHN&C08J-&:QC#0X$>*T(&PWA.,)PVT.R
MVVC"<8QA*<8QCQU177)=$1T1).[QW_C.$O\ M%A?\6O=9(^?A\U1W%O?\PL/
M[MDK;H/D]VYIF@5IFYWF*V/99&GU$F1&B![/90[EIY^%@7Y4QX<2-:EI%L<%
MPXE]E@5+^7W7$-H4K$,X.OPM]4=Q;X_);_\ [)7NF_YO*H_T^Z__ .J.EF=9
M^_!+OZA]^*VMI'>//RW;0JU=W1PSKFJ]9R*Y?%FOH.WZ=9RH! T#*&Q*FH.+
MGC3SOJ,Z-&1"\,#._+MGK+<]#3#CB8(;;0F_WV*077U M]]JBQR9_;*\'_YI
M)K_@;QZD>P>_Z(?:;X^2_''M";)WH.8<Q-_II"IZ>AXRNL/??  :H_3$<HD1
M*ONUE8BGL*4CQA6)DM2L9R1G/0^P._ZJ ?7/=\-//BG;=45T=$1T1'1$=$1T
M1'1$=$1T1'1$=$1T1'1$=$1T1'1$=$1T1'1$=$5"[XBGD\9N+FNSI"+D5O4G
MC-5@:V@1IW*PR-B78*-M=WE$>,X3E\>.>J=5?;4G*A3*R<E"OT[F.N%KY"^;
M<!]6, 6_Q'4GW6'@5Z_^A-D&++.RM^;*B$-Q7/F(2UQD<VTK,$PF6?#L*IS?
M7<?.W$L08X$"2*OB)'J-*65P%Y,T_B+RCUUN_8&JZ_N&F5Q\P6P52:AH68D1
M1)!CVVK/2_KZ%QL;=ZT:V+*P,@ZH?*LL$QOST<B17("Z\$@BE:]S0\#B" 3W
MB_YAQ"^\[8LAXGM)V?XWE/!LPUF6<4KF124>(TM554L$DD+]YU!BGX,B>?":
M^(R4]9"T/ WXY^AG, AD:SOGXDKFG?)TY.CJQK30U02^Y]):7!,[*NV1_5G"
M,S4_;&\U@EW*<)5AN,H\8EE2EMJ>+QA+G6R_$)G'U U@Y:;SO$G3W-"Z\90]
M!G9;A%)$<V8ACV;\2+1^)<VK=@6%;]M12T>'._2$;;W%Y\6G+@ X-CU:L+U/
M\1GW!Z/-#%;#)U5NN!R\CZC#V6A1U0D%B^K&7414UKO-9:CS,I_*R5(1$X,U
MG.5.1Q'VQBK:^<'UMUXZBT#W%MO(KE<Q^A%L8Q:EDCP5F8<JUFZ>@J:#&)\3
MA;);U344N-_CW3Q7U?'#4TDCN#9V)LN(7MY?$":PLYU5@1>._.&HP'U0M]QB
M.S<A,HPT(*;.%QC,<)NK5:Y%T2+*EWPP;;5EOBHPQ552H8T[M6@KFD@".8"_
M;XFPWV]O$=G/KE^*VT^AIC^'PXC6/SKLHQ.L_#QL:^?]%RWWI)(J2.H=/+E7
M,(A;+4,IF2RX;B ;(2_$13R24GOD"N$/P].D:X/FMQV^^<NQZVHIPU.10[++
M(7ZAY$[ZP6-(/ZJTR))M/1L<+'A/SUV,!RD@>:)C)20KC]30M&G23.'CVZ_D
M;\3V\J0Q[5_32S96O_'3Y/V2X'7"-L1Z26@IB+/AA_#1O@9F'-$D#F3SR32L
MH\*BFNQ]*R>GAKME<T^=/(6<[*FM^8=,M6=/[BV7,Z_,D9+6GS48/$!3=SG8
MPR)AERY4S(,"N1X(K#KSQKQ;BDN.X>;]ST)M+,\T;90=Q[MWV=+>M;2]UP6R
MS9)DND]*C'-F6*8?_P 398P*FQF*&#'>CG?4RTF%TD\535"FCI87R-FED>UK
M(F1M!#=P[MS7,TYWR.Y+J&:$D']\/;6A6GD.&U+;U=@[;$RB$*QG++\R.)$W
M8%*D^I/JA[7&YSZO*_<]*<8T&5E0P^WO#J< ;^-M[W%=W<S^B9L,S+220LR@
MW+M6YA;#B66JVKPZHIR0;.;2OEJ<*F(-C_S.'3\+"US=]E.OG"#XA'3<Y1;M
M4X_1/-G7]8<-B)47(LA9H=IE26F+#59S#483LC5*Y,EEBSTB;2S)5IR25@98
M!I,+<3=T.AKF$$!DP&G,CM!TWFWXM/#W%=/L3P?:QZ&&:*3%L)Q*?-VRK&:]
ML533R"2&@JG.!<^BQ"DWJB/ \Q"G8]]!BM(705[8 7B:)E5AD50'?VB]B\:-
MQW_1FUXCZ+>]<SS\%-#-J6Z$8C#;9<7-Q!+C;*C8*PQ)(,Y!G99:R9$R A"F
MFEN*:1Q3V.C>YCM"TV/U\1J%Z6Y-S=@F?,L8-FW+M3^*PC&Z-E72O< V6(W=
M'44E3&USQ%6453'+25<.\[HJB&1@<X .-U_X<KD\9N/AQ8-(6*14=9^,MO;@
M(S+[N7B?W,KXF0L-+2\XYG+J\1LV%=X$-O\ ,T'"Q$.&UE+;2&D<Q02;\183
M<QFP_==<CX[P'8 %Y6>F[D&++&TZCS70PB*@SYAIK9PQH;'^GL(,-%BA8&^J
M.GI9<*K)3HZ6JJ:F5URXN-A'K>73!'1%J_=_]Y;;W\U]_P#^5);J1Q'>/-0>
M![CY)=W9<_P&ZW_.'L3_ /;,]6?Q\/F5#/9'CYE-AZHK)47=RW+,U/04!H.A
M>Z5M'E-;8_5]>BPW/2>_7'38Y-GPQC&?S)F")"!ISK2T^EX6TEY2K"F,YQ=@
MUOR"JXG0#B?+FL5IW9XH-7JT%!,\H^6L+F/CF$%QU.V;"P%78E'D_,RZX*&1
M37/I\<5*O&%L#N.OD8P_ZB2""%.O.1O=C?<F[VN]Z_=M[/&O;16YF!,Y1\N)
MEN0!=0S'6W9L)/UMX]GP3%N3,,[36TR (LDR(6Z.AYAY7L84.0.0EM]MO=C?
M<A;_ (G>)4"M:UJZ<G>V[OKA],@D$;_X5[ <E:_65^HF4.C("5GU_1A&\X^8
M.D!A\[)I\4,,A249;JPF,X06TWU;0.!Y.^[^7Q5>+2.;?OC[PG1\ ^3=?Y0<
M;Z+:1I,=^\U:%BJ=M&%4ZGZE$W&%!;!*.*%SGW6@+0@7\01#_P"D9<&,<#]]
M9T=(-,4<+'R5P00IK=0I2D.Z_P @;74J'KKCGI"SV&,Y#;XO=8CZZ/1YZ1@K
M;%5D671A<@B4A"AI2(;G[$B*@!U9>'9DX[\2XRZX-&'M]6:.)/ ??WX*KCP
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MJ'DO['M3*V0*RV6-D0D:HQ))4@Z*_P#(J5$)EB"L*'ADXC(.-KT>^:$4+KZ
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M&,1H#);<N7B+V/WU)Z_P^NXZ_N/M,\4WH<T=^3UG 6/3EM :<0M^%G]?VJ7
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M?T9283Q:X$<OO4*.?-3O2;^[R&M++P1[8_#3=I\7N!R,KVT-EW,6'Q+1M/\
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MARN3U@^23RN^<^B0\A*_*?,9XW?+_,_(#O\ L>_[#WL^[Z/=]EWT>KVU^"B
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MQQST5%VB6G(TL,;]PZ\#H?JE$<8/B2]V<)X**XQ=V/BCOAO:&M &*ZULV B
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6>,8QC'VQC&/MC&/MC'1%YZ(CHB__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
